Is Banka BioLoo a Good Buy After Its Q1 FY27 Results?

Banka BioLoo share price around Rs 81. 17.2% below 52-week high of Rs 98. Q1 FY27 revenue Rs 11 crore, down 12.6% YoY. loss of Rs 0.04 crore.

The Banka BioLoo share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Banka BioLoo is a provider of bio-toilet and sustainable sanitation technology solutions, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.

Revenue for the quarter came in at Rs 11 crore, down 12.6% year on year, while the company reported a net loss of Rs 0.04 crore. That combination of numbers is exactly what this article breaks down, along with what it means for the Banka BioLoo share price from here.

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Banka BioLoo share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.

Click Here – Get Free Investment Predictions

Banka BioLoo Q1 FY27 Financial Highlights

Banka BioLoo Q1 FY27 Performance Analysis

Check Banka BioLoo Fundamentals on Univest Screener

Revenue declined 12.6% for the quarter, which was not offset by cost control, and the bio-toilet and sanitation technology business will need a stronger showing next quarter to reverse the trend.

The quarter’s most important number is the swing to a net loss of Rs 0.04 crore, a reversal from the profit reported a year earlier. The revenue trend does not offset this either, and the Banka BioLoo share price should be judged on when profitability is likely to return rather than on the topline trend.

On a sequential basis, revenue moved down 40.2% sequentially from Rs 18 crore in the March 2026 quarter and the net loss moved down 102.5% sequentially from Rs 1.60 crore in the prior quarter, giving a fuller picture of the trend behind the Banka BioLoo share price than the year on year comparison alone.

Key Business Factors in Q1 FY27

Revenue Trend

Banka BioLoo’s revenue declined 12.6% year on year this quarter, taking the quarterly base to Rs 11 crore in a bio-toilet and sanitation technology business that remains sensitive to demand and pricing cycles that ultimately feed through to the Banka BioLoo share price.

Margin Movement

EBITDA rose 37.1% to Rs 1.92 crore, and operating margin moved to 18.2% from 12.7% a year earlier, a sign that cost control or pricing held up during the quarter.

Balance Sheet Position

Banka BioLoo’s debt-to-equity ratio stands at 1.03, a level worth monitoring given the quarter’s margin trend.

Valuation Context

Banka BioLoo does not carry a meaningful PE multiple this quarter given its current earnings, so investors should lean on revenue and book value trends instead of the price-to-earnings ratio when assessing the Banka BioLoo share price.

Dividend Details

No interim dividend was declared alongside Banka BioLoo’s Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Banka BioLoo share price for income should watch the company’s announcements around its next annual results for any dividend decision.

Banka BioLoo Share Price Outlook for FY27

Banka BioLoo’s path back to profitability is the central question for FY27. Revenue growth is a positive signal, but until the company demonstrates it can convert that growth into profit again, the Banka BioLoo share price is likely to stay sensitive to every quarterly update.

Investors should track cost trends and any management commentary on when profitability is expected to normalise, since that timeline will likely matter more to the Banka BioLoo share price than revenue growth alone.

Banka BioLoo Stock Performance

Download the Univest iOS App or Univest Android App to track Banka BioLoo’s live share price and get daily stock updates.

The Banka BioLoo share price was trading around Rs 81 as results season played out in late August 2026, roughly 17.2% below its 52-week high of Rs 98 and well above its 52-week low of Rs 41.

The Banka BioLoo share price has likely already absorbed some of this quarter’s disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off. On profitability ratios, the company reports a return on equity of 1.63% and a book value of around Rs 36 per share, both useful reference points when judging whether the current price is reasonable.

Key Risks

Profitability Risk

The quarter’s profit trend is the clearest risk here. Until Banka BioLoo shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.

Leverage Risk

A debt-to-equity ratio of 1.03 means the company’s earnings are more sensitive to interest rate and refinancing conditions than a lower-debt peer.

Sector and Demand Risk

As a bio-toilet and sanitation technology business, Banka BioLoo’s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Banka BioLoo share price well before the next result.

Conclusion

Banka BioLoo’s swing to a net loss of Rs 0.04 crore in Q1 FY27 is the standout number from this result, with revenue also under pressure. The Banka BioLoo share price is best approached cautiously until the company shows a credible path back to profitability, and this quarter alone does not make a strong case to buy.

Frequently Asked Questions on Banka BioLoo Q1 FY27 Results

What were Banka BioLoo’s Q1 FY27 results?

Ans. Banka BioLoo reported Q1 FY27 revenue of Rs 11 crore, down 12.6% year on year, with a net loss of Rs 0.04 crore.

Is Banka BioLoo a good buy after its Q1 FY27 results?

Ans. Banka BioLoo’s profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.

What is the Banka BioLoo share price today?

Ans. The Banka BioLoo share price was trading around Rs 81 in late August 2026, about 17.2% below its 52-week high of Rs 98 and well above its 52-week low of Rs 41.

What is Banka BioLoo’s revenue and profit for Q1 FY27?

Ans. Banka BioLoo reported revenue of Rs 11 crore and a net loss of Rs 0.04 crore for the quarter ended June 30, 2026.

Did Banka BioLoo declare a dividend with its Q1 FY27 results?

Ans. No interim dividend was declared alongside Banka BioLoo’s Q1 FY27 results. Investors should track the company’s next annual results for any dividend announcement.

Why does Banka BioLoo not have a meaningful PE ratio?

Ans. Banka BioLoo does not carry a meaningful price-to-earnings ratio currently because of its recent earnings performance. Investors should use revenue and book value trends instead when assessing the stock.

What are the key risks for Banka BioLoo investors right now?

Ans. The quarter’s profit trend is the clearest risk here. Until Banka BioLoo shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. As a bio-toilet and sanitation technology business, Banka BioLoo’s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Banka BioLoo share price well before the next result.

What is Banka BioLoo’s promoter shareholding?

Ans. Promoter shareholding data for Banka BioLoo was not fully available for this quarter and should be checked on the company’s official filings.